Nonmyeloablative Allogeneic Hematopoietic Transplantation: A Promising Salvage Therapy for Patients With Non-Hodgkin's Lymphoma Whose Disease Has Failed a Prior Autologous Transplantation We included ...

Joshua Richter, MD, assistant professor of medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology, explains how the concept of cancer stage does not mean the same thing in ...

Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...

Panelists discuss how NCCN guidelines are expected to incorporate quadruplet-based regimens as reasonable treatment approaches for transplant-ineligible patients, while emphasizing the need for ...

The term “gene” was introduced in 1909 to refer to the fundamental unit of inheritance. Then, just a few years later, in 1914, the existence of cancer-causing genes was predicted to account for the ...

New research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately. Sometimes even better than all existing techniques together, ...

Life sciences company Bionano (BNGO) has drawn a lot of attention this year due its potential to disrupt the cytogenetics field - the study of chromosomes. Bionano’s optical genome mapping (OGM) ...